The Multidimensional Challenge of Treating Coronavirus Disease 2019 (COVID-19): Remdesivir Is a Foot in the Door
Author:
Affiliation:
1. Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Funder
Harvard University Center for AIDS Research
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Microbiology (medical)
Link
http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa1132/33776123/ciaa1132.pdf
Reference19 articles.
1. Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 Cases From the Chinese Center for Disease Control and Prevention;Wu;JAMA,2020
2. Mild or moderate Covid-19 [published online ahead of print, 2020 Apr 24];Gandhi;N Engl J Med,2020
3. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020
4. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19;Ackermann;N Engl J Med,2020
5. Dexamethasone in hospitalized patients with Covid-19–preliminary report [published online ahead of print, 2020 Jul 17];Horby;N Engl J Med,2020
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Favipiravir for treating COVID-19;Cochrane Database of Systematic Reviews;2024-02-05
2. COVID-19 related ICU admissions in paediatric and young adult patients in Australia: a national case series 2020–2022;The Lancet Regional Health - Western Pacific;2023-07
3. Efficacy of the combination of monoclonal antibodies against the SARS-CoV-2 Beta and Delta variants;PLOS ONE;2023-05-04
4. Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials;Clinical Microbiology and Infection;2023-01
5. Lessons learned from an outbreak of COVID-19 in the head and neck surgery ward of a Japanese cancer center during the sixth wave by Omicron;Journal of Infection and Chemotherapy;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3